Synthesis of new aryl(hetaryl)-substituted tandospirone analogues with potential anxiolytic activity via reductive Heck type hydroarylations

[1] Amano, T., Akbar, M., Matsubayashi, H., & Sasa, M. (2001). Inhibitory effects of tandospirone, a 5-HT1A agonist, on medial vestibular nucleus neurons responding to lateral roll tilt stimulation in rats. Brain Research, 910, 195–198. DOI: 10.1016/s0006-8993(01)02698-1. http://dx.doi.org/10.1016/S0006-8993(01)02698-110.1016/S0006-8993(01)02698-1Suche in Google Scholar

[2] Bagdatli, E., Ocal, N., & Kaufmann, D. E. (2007). An investigation into domino-Heck reactions of N-acylaminosubstituted tricyclic imides: Synthesis of new prospective pharmaceuticals. Helvetica Chimica Acta, 90, 2380–2385. DOI: 10.1002/hlca.200790244. http://dx.doi.org/10.1002/hlca.20079024410.1002/hlca.200790244Suche in Google Scholar

[3] Beletskaya, I. P., & Cheprakov, A. V. (2000). The Heck reaction as a sharpening stone of palladium catalysis. Chemical Reviews, 100, 3009–3066. DOI: 10.1021/cr9903048. http://dx.doi.org/10.1021/cr990304810.1021/cr9903048Suche in Google Scholar

[4] Celik, C., Kulu, I., Ocal, N., & Kaufmann, D. E. (2009). Domino-Heck reactions of carba- and oxabicyclic, unsaturated dicarboximides: Synthesis of aryl-substituted, bridged perhydroisoindole derivatives. Helvetica Chimica Acta, 92, 1092–1101. DOI: 10.1002/hlca.200800388. http://dx.doi.org/10.1002/hlca.20080038810.1002/hlca.200800388Suche in Google Scholar

[5] Godfrey, A. G., Kohlman, D. T., O’Toole, J. C., Xu, Y. C., & Zhang, T. Y. (2006). U.S. Patent No. 7001908 B2. Washington, DC, USA: U.S. Patent and Trademark Office. Suche in Google Scholar

[6] Göksu, G., Gül, M., Öcal, N., & Kaufmann, D. E. (2008). Hydroarylation of bicyclic, unsaturated dicarboximides: access to aryl-substituted, bridged perhydroisoindoles. Tetrahedron Letters, 49, 2685–2688. DOI: 10.1016/j.tetlet.2008.02.171 http://dx.doi.org/10.1016/j.tetlet.2008.02.17110.1016/j.tetlet.2008.02.171Suche in Google Scholar

[7] Goksu, G., Ocal, N., & Kaufmann, D. E. (2010). Reductive Heck reactions of N-methyl-substituted tricyclic imides. Molecules, 15, 1302–1308. DOI: 10.3390/molecules15031303. http://dx.doi.org/10.3390/molecules1503130310.3390/molecules15031303Suche in Google Scholar

[8] Grundt, P., Carlson, E. E., Cao, J., Bennett, C. J., McElveen, E., Taylor, M., Luedtke, R. R., & Newman, A. H. (2005). Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. Journal of Medicinal Chemistry, 48, 839–848. DOI: 10.1021/jm049465g. http://dx.doi.org/10.1021/jm049465g10.1021/jm049465gSuche in Google Scholar

[9] Grundt, P., Prevatt, K. M., Cao, J., Taylor, M., Floresca, C. Z., Choi, J. K., Jenkins, B. G., Luedtke, R. R., & Newman, A. H. (2007). Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: Potential substance abuse therapeutic agents. Journal of Medicinal Chemistry, 50, 4135–4146. DOI: 10.1021/ jm0704200. http://dx.doi.org/10.1021/jm070420010.1021/jm0704200Suche in Google Scholar

[10] Ishihara, Y., Bazzi, H. S., Toader, V., Godin, F., & Sleiman, H. F. (2007). Molecule-responsive block copolymer micelles. Chemistry — A European Journal, 13, 4560–4570. DOI: 10.1002/chem.200601423. http://dx.doi.org/10.1002/chem.20060142310.1002/chem.200601423Suche in Google Scholar

[11] Kishimoto, K., Koyama, S., & Akaike, N. (2000). Presynaptic modulation of synaptic -aminobutyric acid transmission by tandospirone in rat basolateral amygdala. European Journal of Pharmacology, 407, 257–265. DOI: 10.1016/s0014-2999(00)00673-7. http://dx.doi.org/10.1016/S0014-2999(00)00673-710.1016/S0014-2999(00)00673-7Suche in Google Scholar

[12] Kossakowski, J., & Jarocka, M. (2001). Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XVII. Derivatives of 1-ethoxybicyclo[2.2.2]-oct-5-one-2,3-dicarboximide. Il Farmaco, 56, 785–789. DOI: 10.1016/s0014-827x(01)01144-2. http://dx.doi.org/10.1016/S0014-827X(01)01144-210.1016/S0014-827X(01)01144-2Suche in Google Scholar

[13] Kossakowski, J., Bielenica, A., Mirosław, B., Koziol, A. E., Dybala, I., & Struga, M. (2008). 4-Azatricyclo[5.2.2.02,6]undecane-3,5,8-triones as potential pharmacological agents. Molecules, 13, 1570–1583. DOI: 10.3390/molecules13081570. http://dx.doi.org/10.3390/molecules1308157010.3390/molecules13081570Suche in Google Scholar

[14] Kulig, K., Sapa, J., Nowaczyk, A., Filipek, B., & Malawska, B. (2009). Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and α-adrenolytic activity. European Journal of Medicinal Chemistry, 44, 3954–4003. DOI: 10.1016/j.ejmech.2009.04.028. http://dx.doi.org/10.1016/j.ejmech.2009.04.02810.1016/j.ejmech.2009.04.028Suche in Google Scholar

[15] Kulu, I., & Ocal, N. (2011). The synthesis of epiboxidine and related analogues as potential pharmacological agents. Helvetica Chimica Acta, 94, 2054–2060. DOI: 10.1002/hlca.201100140. http://dx.doi.org/10.1002/hlca.20110014010.1002/hlca.201100140Suche in Google Scholar

[16] Kulu, I., Kopruceli, A., Goksu, G., & Ocal, N. (2012) Synthesis of new aryl(hetaryl)-substituted tandospirones under reductive Heck type hydroarylations and isoxazoline derivatives via 1,3-dipolar cycloaddition reactions with expected anxiolytic activity. Current Organic Synthesis. In press. DOI: 10.2174/1570212700121661794. Suche in Google Scholar

[17] Makan, S. Y., Tsymbal, D. I., Soboleva, S. G., Tarabara, I. N., Kas’yan, L. I., & Andronati, S. A. (2009). N-[4-(Arylpiperazin-1-yl)butyl]bicyclo[2.2.1]hept-5-ene-endo-2, endo-3-dicarboximides and their epoxy derivatives. Synthesis and affinity for 5-HT1a receptors. Russian Journal of General Chemistry, 79, 292–296. DOI: 10.1134/s1070363209020212. http://dx.doi.org/10.1134/S107036320902021210.1134/S1070363209020212Suche in Google Scholar

[18] Mitchell, D., & Yu, H. (2003). Synthetic applications of palladium-catalyzed hydroarylation and related systems. Current Opinion in Drug Discovery and Development, 6, 876–883. Suche in Google Scholar

[19] Namyslo, J. C., & Kaufmann, D. E. (1999). Chemistry in the ambient field of the alkaloid epibatidine. Part 2. Triphenylarsine as an efficient ligand in the Pd-catalyzed synthesis of epibatidine and analogs. Synlett, 1999, 114–116. DOI: 10.1055/s-1999-2528. 10.1055/s-1999-2528Suche in Google Scholar

[20] Namyslo, J. C., Storsberg, J., Klinge, J., Göttner, C., Yao, M. L., Ocal, N., & Kaufmann, D. E. (2010). The hydroarylation reaction—scope and limitations. Molecules, 15, 3402–3410. DOI: 10.3390/molecules15053402. http://dx.doi.org/10.3390/molecules1505340210.3390/molecules15053402Suche in Google Scholar

[21] Negishi, E. I., & de Meijere, A. (2002). Handbook of organopalladium chemistry for organic synthesis. New York, NY, USA: Wiley. http://dx.doi.org/10.1002/047147380410.1002/0471473804Suche in Google Scholar

[22] Nishikawa, H., Inoue, T., Izumi, T., & Koyama, T. (2007). Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats. European Neuropsychopharmacology, 17, 643–650. DOI: 10.1016/j.euroneuro.2007.02.010. http://dx.doi.org/10.1016/j.euroneuro.2007.02.01010.1016/j.euroneuro.2007.02.010Suche in Google Scholar

[23] Pickard, G. E., & Rea, M. A. (1997). TFMPP, a 5HT1B receptor agonist, inhibits light-induced phase shifts of the circadian activity rhythm and c-Fos expression in the mouse suprachiasmatic nucleus. Neuroscience Letters, 231, 95–98. DOI: 10.1016/s0304-3940(97)00534-x. http://dx.doi.org/10.1016/S0304-3940(97)00534-X10.1016/S0304-3940(97)00534-XSuche in Google Scholar

[24] Przegaliński, E., Baran, L., & Siwanowicz, J. (1994). Role of 5-hydroxytryptamine receptor subtypes in the 1-[3-(trifluoromethyl)phenyl]piperazine-induced increase in threshold for maximal electroconvulsions in mice. Epilepsia, 35, 889–894. DOI: 10.1111/j.1528-1157.1994.tb02528.x. http://dx.doi.org/10.1111/j.1528-1157.1994.tb02528.x10.1111/j.1528-1157.1994.tb02528.xSuche in Google Scholar

[25] Sarswat, A., Kumar, R., Kumar, L., Lal, N., Sharma, S., Prabhakar, Y. S., Pandey, S. K., Lal, J., Verma, V., Jain, A., Maikhuri, J. P., Dalela, D., Gupta, G., & Sharma, V. L. (2011). Arylpiperazines for management of benign prostatic hyperplasia: Design, synthesis, quantitative structure-activity relationships, and pharmacokinetic studies. Journal of Medicinal Chemistry, 54, 302–311. DOI: 10.1021/jm101163m. http://dx.doi.org/10.1021/jm101163m10.1021/jm101163mSuche in Google Scholar

[26] Staack, R. F., Fritschi, G., & Maurer, H. H. (2003). New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/ mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine. Journal of Mass Spectrometry, 38, 971–981. DOI: 10.1002/jms.513. http://dx.doi.org/10.1002/jms.51310.1002/jms.513Suche in Google Scholar

[27] Takahashi, T., Mitsuya, H., Murata, T., Murayama, J., & Wada, Y. (2008). Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder. Sleep Medicine, 9, 317–319. DOI: 10.1016/j.sleep.2007.05.003. http://dx.doi.org/10.1016/j.sleep.2007.05.00310.1016/j.sleep.2007.05.003Suche in Google Scholar

[28] Tindale, J. J., Hartlen, K. D., Alizadeh, A., Workentin, M. S., & Ragogna, P. J. (2010). Maleimide-modified phosphonium ionic liquids: A template towards (multi)task-specific ionic liquids. Chemistry — A European Journal, 16, 9068–9075. DOI: 10.1002/chem.200902610. http://dx.doi.org/10.1002/chem.20090261010.1002/chem.200902610Suche in Google Scholar

[29] Yolacan, Ç., Bagdatli, E., Öcal, N., & Kaufmann, D. E. (2006). Epibatidine alkaloid chemistry: 5. Domino-Heck reactions of azabicyclic and tricyclic systems. Molecules, 11, 603–614. DOI: 10.3390/11080603. http://dx.doi.org/10.3390/1108060310.3390/11080603Suche in Google Scholar

[30] Wei, Z. L., George, C., & Kozikowski, A. P. (2003). Synthesis of 5-endo-, 5-exo-, 6-endo- and 6-exo-hydroxylated analogues of epibatidine. Tetrahedron Letters, 44, 3847–3850. DOI: 10.1016/s0040-4039(03)00737-8. http://dx.doi.org/10.1016/S0040-4039(03)00737-810.1016/S0040-4039(03)00737-8Suche in Google Scholar